Tag archive for ‘Federal Circuit’
Shiri Habib-Valdhorn On Tuesday, January 27th, 2015

Teva rivals urge US court to expedite Copaxone suit

Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) who are developing a More...

Nadav Neuman On Wednesday, January 21st, 2015

US Supreme Court upholds Copaxone patent

The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015.   The US Supreme Court has ruled in favor of Teva Pharmaceutical Industries Ltd. (NYSE: More...

Jewish Business News On Tuesday, June 17th, 2014

Teva Reaches Settlements In NUVIGIL Patent Case

– – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to U.S. Patent 7, 132, 570 (the “570 patent”) for More...

Wordpress site Developed by Fixing WordPress Problems